Picard Medical Investors Pressed to Join Securities Class Action as Lead-Plaintiff Deadlines Near

Overview

• New notices from Rosen Law Firm, The Schall Law Firm, and Levi & Korsinsky invite anyone who bought Picard Medical stock between September 2 and October 31, 2025 to join the case.
• The complaints say a social media promotion used false posts and fake financial advisors to push the share price higher.
• Filings also claim insiders or affiliates sold stock through offshore or nominee accounts during the run-up.
• The lawsuits cite Sections 10(b) and 20(a) of the Exchange Act and SEC Rule 10b-5, and the class has not been certified.
• Investors can seek to be lead plaintiff, who helps steer the case, but they may still share in any recovery without taking that role.